Status:
COMPLETED
A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Testicular Cancer
Eligibility:
MALE
18-120 years
Brief Summary
The incidence of testicular germ cell tumors (TGCT) has increased during the twentieth century and is of particular concern as it primarily affects young men. It is the most common cancer among U.S. m...
Detailed Description
The incidence of testicular germ cell tumors (TGCT) has increased during the better part of the twentieth century and is of particular concern as it primarily affects young men. Though the tumor is re...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- The identification of men who have had a diagnosis of testicular germ cell tumor (TCGT) will be accomplished by the linking of databases maintained by the Department of Defense. Potential cases will be initially identified through the Defense Medical Surveillance System (DMSS).
- Matched controls will be identified through the DMSS.
- Criteria for Cases include:
- Age between 17 and 45 years at time of confirmed TGCT diagnosis.
- Age of at least 18 years at time of study enrollment.
- The existence of a pre-diagnostic serum sample of 1mL or greater in the DoDSR.
- On active duty at time of diagnosis.
- Donated a serum sample to the DoDSR between the years 1989 and 2003.
- Criteria for Control Identification:
- Case subjects will be matched with case men on age, ethnicity, and date of serum donation to men in the DoDSR who have never had a diagnosis of TGCT (control men).
- Criteria for Control Men include:
- No previous diagnosis of TGCT.
- Donated a serum sample to the DpDSR between the years 1989 and 2003.
- Alive at study initiation.
- On active duty at time of case's diagnosis.
Exclusion
Key Trial Info
Start Date :
January 18 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 18 2020
Estimated Enrollment :
2772 Patients enrolled
Trial Details
Trial ID
NCT00341588
Start Date
January 18 2002
End Date
August 18 2020
Last Update
August 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892